FFRangio: New Software Derives FFR Value from Angiography

Original Title: Image-based FFR during coronary catheterization.
Presenter: Mariano Pellicano.

 

Fractional flow reserve (FFR) is considered the gold standard to detect myocardial ischemia; however, due to its elevated cost, increased procedural time and potential complications associated to the guiding catheter, it is still underused.

The FFRangio is a new technology based of angiographic images that allows near real-time non-invasive estimation of FFR. The aim of this study was to assess the diagnostic precision of FFRangio.

Based on 3 to 4 angiographic projections after administrating intracoronary nitroglycerine, with lower magnification than usual in order to avoid following the artery, a software reconstructs the coronary tree in 3D for the FFRangio, simulating flow and resistance, allowing the estimation of pressures in a few minutes, with good correlation with the invasive FFR. FFRangio holds great promise as a cost effective tool and should be validated by larger studies.

More articles by this author

SYNTAX II: Initial outcomes of FFR/iFR and IVUS guided PCI with last generation DES in 3 vessel patients

Original Title: iFR/FFR and IVUS-guided percutaneous coronary revascularization with new-generation DES in patients with de novo three-vessel disease: 30-day outcomes of the SYNTAX II...

PRIME-FFR: Safe in acute coronary syndrome

Original Title: Impact of routine Fractional Flow Reserve on management decision and 1-year clinical outcome of ACS patients: Insights from the POST-IT and R3F...

FAVOR: Diagnostic Accuracy of FFR derived from coronary angiography, the QFR

Original Title: Diagnostic accuracy of a fast computational approach to derive FFR from coronary X-ray angiography: results from the international multicenter FAVOR (Functional Assessment...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...